Which leukotriene receptor antagonist is widely used for asthma control?

Montelukast is the most widely used leukotriene receptor antagonist for asthma control due to its favorable safety profile, once-daily dosing convenience, and its effectiveness in reducing inflammation and bronchoconstriction associated with asthma. It specifically inhibits the action of leukotrienes, which are inflammatory mediators that can lead to bronchoconstriction and increased mucus production in asthma patients. Montelukast has been extensively studied and is a recommended option in asthma management guidelines for both adults and children, making it a common choice in clinical practice.

While zafirlukast is another leukotriene receptor antagonist, it has less widespread use, primarily due to the need for more frequent dosing and potential liver toxicity. The name Singulair is the brand name for montelukast, which highlights its popularity further, but it is effectively the same medication. Asthalin, on the other hand, is a brand name for salbutamol (also known as albuterol), which is a short-acting beta-agonist used primarily for quick relief of asthma symptoms, rather than for long-term control. Thus, montelukast stands out as the leading choice in this category for asthma management.